» Articles » PMID: 18291704

Assembly-dependent Endocytosis and Clearance of Extracellular Alpha-synuclein

Overview
Publisher Elsevier
Date 2008 Feb 23
PMID 18291704
Citations 241
Authors
Affiliations
Soon will be listed here.
Abstract

Abnormal folding and accumulation of alpha-synuclein is implicated in several neurological disorders including Parkinson's disease. Although alpha-synuclein is a typical cytoplasmic protein, a small amount of both monomeric and aggregated forms is secreted from cells and is present in human body fluids, such as cerebrospinal fluid. Extracellular alpha-synuclein aggregates have been shown to be neurotoxic, posing a challenge to any cell exposed to them. Here, we examine the internalization of various forms of extracellular alpha-synuclein, including fibrils, oligomers, and monomer, into neuronal cells and their subsequent degradation. Internalization of fibrillar alpha-synuclein could be inhibited by low temperature or the expression of a dominant-negative mutant dynamin-1 K44A, suggesting the endocytosis-mediated internalization. The internalized fibrils moved through the endosomal pathway and were degraded in the lysosome, which ultimately resulted in the clearance of the alpha-synuclein aggregates from the culture medium. Non-fibrillar oligomeric aggregates were also internalized via endocytosis and degraded by the lysosome. In contrast to aggregate uptake, the internalization of monomeric alpha-synuclein was unaffected by cold temperature and the expression of dynamin-1 K44A, consistent with direct translocation across the plasma membrane. Internalized monomers rapidly pass the plasma membrane, escaping the cells before being degraded by the cellular proteolytic systems. These results suggest that only aggregated forms of extracellular alpha-synuclein can be cleared by cell-mediated uptake and degradation, and this might represent a mechanism of preventing neurons from exposure to potentially toxic alpha-synuclein.

Citing Articles

Design and Development of Natural-Product-Derived Nanoassemblies and Their Interactions with Alpha Synuclein.

Banerjee I, Das A, Biggs M, Phan C, Cutter L, Ren A Biomimetics (Basel). 2025; 10(2).

PMID: 39997105 PMC: 11852371. DOI: 10.3390/biomimetics10020082.


Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions.

Kuo G, Kumbhar R, Blair W, Dawson V, Dawson T, Mao X Mol Neurodegener. 2025; 20(1):10.

PMID: 39849529 PMC: 11756073. DOI: 10.1186/s13024-025-00797-1.


A nanoparticle-based wireless deep brain stimulation system that reverses Parkinson's disease.

Wu J, Cui X, Bao L, Liu G, Wang X, Chen C Sci Adv. 2025; 11(3):eado4927.

PMID: 39813330 PMC: 11734722. DOI: 10.1126/sciadv.ado4927.


TNBS colitis induces architectural changes and alpha-synuclein overexpression in mouse distal colon: A morphological study.

Casini A, Vivacqua G, Ceci L, Leone S, Vaccaro R, Tagliafierro M Cell Tissue Res. 2024; 399(2):247-265.

PMID: 39656240 PMC: 11787265. DOI: 10.1007/s00441-024-03932-4.


Emerging role of microglia in inter-cellular transmission of α-synuclein in Parkinson's disease.

Zhang X, Yu H, Feng J Front Aging Neurosci. 2024; 16:1411104.

PMID: 39444806 PMC: 11496080. DOI: 10.3389/fnagi.2024.1411104.